Walgreens Boots Alliance, Inc. is recalling a line of women's multivitamins because the packaging is not child-resistant.
The CDMO unveiled initiatives that include additional staff for daily clinical manufacturing...
Seattle Genetics has a substantial portfolio of cancer targets and tumor-specific monoclonal...
The novelty covers the method of preparing master cell banks, working cell banks and the final...
A total of 87 people in South Korea have been infected by MERS since last month in the largest outbreak outside the Middle East. About 1,870 schools have closed and more than 2,000 people are isolated at their homes or state-run facilities after having contact with patients infected with the virus.
TWi Pharmaceuticals announced it received final approval from the FDA for its Guanfacine HCl ER tablet.
The drug — named brodalumab — led to suicidal thoughts among trial patients, which could result in regulators attaching a warning label to the product.
The U.S. has a drug shortage problem that refuses to go away. Here's a look at what it means for manufacturers, patients and doctors.
Perrigo will acquire a portfolio of well-established over-the-counter brands from GlaxoSmithKline Consumer Healthcare.
Lannett Company announced that it has completed the acquisition of privately held Silarx Pharmaceuticals - a manufacturer and marketer of liquid generic pharmaceutical products.
The makers of a pill intended to boost sexual desire in women will try again this week to persuade regulators that the drug warrants approval after two rejections.
This strategic investment will allow the company to increase its manufacturing capabilities and introduce new technologies that will increase the company’s competitiveness and capacity to further diversify in global markets.
Contamination problems and the high cost of regulations have caused manufacturing delays and drug shortages that are only getting worse.
AstraZeneca today announced that it plans to invest approximately $285 million in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that ...
Doctors turned powdered plastic into tiny devices that saved the lives of three baby boys by holding open defective airways so they could breathe.
The company says it is tripling production of its new, fast-acting, inhalable insulin for diabetes at its Danbury plant.
Merck easily beat Wall Street expectations despite first-quarter profit plunging 44 percent. The company was hurt by the sale of its consumer health business, unfavorable currency exchange rates and competition to some drugs.
The ruling could force several states to either find new execution drugs or change the way they put prisoners to death.
Bristol-Myers Squibb reported results for the first quarter of 2015, which were highlighted by strong global sales for key brands, important regulatory and clinical milestones and the completion of several strategic transactions.
This video showcases the precision engineering involved when GEA Pharma Systems, G-CON and Pfizer collaborated to develop modular, next generation processing technologies for oral solid dosage forms. The technology was recognized at last week's INTERPHEX with an Exhibitor Award.
The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spenders Regeneron and Vertex, says research and consulting firm GlobalData.
Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the opening of its new greenhouse to facilitate and expand its research and product development capacity.
NeoStem, Inc., a biopharmaceutical company developing novel cell-based individualized medicine therapies, announced today the expansion of manufacturing services under an existing Services Agreement between its wholly-owned subsidiary, PCT, and Kite Pharma.
Catalent Pharma Solutions announced the opening of a large scale expansion at its Winchester, KY, manufacturing facility.
International Pharmaceutical Expo, the premier industry event dedicated to showcasing pharmaceutical and biopharmaceutical innovation, technology and knowledge, today announced ACG North America will feature their line of end-to-end oral solid dosage manufacturing, packaging and inspection technologies, at INTERPHEX 2015.
GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH announced the expansion of Rentschler’s biopharmaceutical manufacturing capabilities.
Ventana, a member of the Roche Group, announced it has entered into a master collaboration agreement with Astellas Pharma Inc.
Watson-Marlow Fluid Technology Group strengthens its biopharmaceutical offering through the acquisition of ASEPCO Corporation (Asepco).
Merck's agreement with AIAC is to sell the manufacturing facility in Arecibo that was under closing plans. AIAC will retain the approximately 200 Merck employees.
- Page 1